Clinical Research Directory
Browse clinical research sites, groups, and studies.
An Evaluation of the Long-Term Safety and Efficacy of TSND-201 for the Treatment of PTSD
Sponsor: Transcend Therapeutics
Summary
This study is evaluating the long-term safety and efficacy of TSND-201 in adults with PTSD. Participants that have completed a double-blind clinical trial with TNSD-201 for PTSD will be invited to participate in this open-label extension trial. Each participant will be able to receive up to three Treatment Courses over the duration of the study (up to 48 weeks). Each Treatment Course includes 4 dosing sessions, spaced one week apart.
Official title: A Phase 3 Open-Label Extension Study to Assess the Long-term Safety and Efficacy of TSND-201 for the Treatment of PTSD
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
300
Start Date
2026-06
Completion Date
2029-01
Last Updated
2026-06-26
Healthy Volunteers
No
Conditions
Interventions
TSND-201
TSND-201 capsules, given orally; where a course of treatment includes dosing with TSND-201 once a week for four consecutive weeks
Locations (1)
CNS Healthcare
Orlando, Florida, United States